BRD2 and colorectal carcinoma: Farkas et al. evaluated DNA methylation changes of genes frequently mutated in CRC using BeadChip450K technology, including 11 of the 12 genes analyzed in our study [49] and reported hypomethylation in CTNNB1 and SMAD2 promoters in CRC compared to NAT samples.